The metagenomic sequencing from The Business Research Company provides comprehensive market statistics, including global market size, regional shares, competitor market share, detailed segments, trends, and opportunities. This report offers an in-depth analysis of current and future industry scenarios, delivering a complete perspective for thriving in the industrial automation software market.
Metagenomic Sequencing Market, 2024 report by The Business Research Company offers comprehensive insights into the current state of the market and highlights future growth opportunities.
Market Size –
The metagenomic sequencing market size has grown rapidly in recent years. It will grow from $1.82 billion in 2023 to $2.13 billion in 2024 at a compound annual growth rate (CAGR) of 16.9%. The growth in the historic period can be attributed to increasing involvement of the government, the growing number of metagenome sequencing research projects, growing application of metagenomics in genomics and diagnostics research, the availability of research funding, the development of NGS data analysis tools.
The metagenomic sequencing market size is expected to see rapid growth in the next few years. It will grow to $4.02 billion in 2028 at a compound annual growth rate (CAGR) of 17.2%. The growth in the forecast period can be attributed to decreasing computational costs, growing focus on discovering novel biomolecules of interest, increasing adoption of high-throughput sequencing technologies, demand for personalized medicine and disease diagnosis, surge in prevalence of infectious diseases. Major trends in the forecast period include innovative technologies, metagenomics utilizes advanced genomic technologies, augmented R&D funding, advancements in sequencing technology, NGS data analysis using big data.
Order your report now for swift delivery @
https://www.thebusinessresearchcompany.com/report/metagenomic-sequencing-global-market-report
Scope Of Metagenomic Sequencing Market
The Business Research Company’s reports encompass a wide range of information, including:
1. Market Size (Historic and Forecast): Analysis of the market’s historical performance and projections for future growth.
2. Drivers: Examination of the key factors propelling market growth.
3. Trends: Identification of emerging trends and patterns shaping the market landscape.
4. Key Segments: Breakdown of the market into its primary segments and their respective performance.
5. Focus Regions and Geographies: Insight into the most critical regions and geographical areas influencing the market.
6. Macro Economic Factors: Assessment of broader economic elements impacting the market.
Metagenomic Sequencing Market Overview
Market Drivers –
The surge in the prevalence of infectious diseases is expected to drive the growth of the metagenomic sequencing market. Infectious diseases are disorders caused by pathogenic microorganisms such as bacteria, viruses, parasites, or fungi that can spread, directly or indirectly, from one person to another. The increasing prevalence of conditions that weaken the immune system, such as HIV/AIDS, cancer treatments, and autoimmune disorders, can make individuals more susceptible to infectious diseases. Metagenomic sequencing offers a powerful and versatile approach to studying infectious diseases, providing valuable insights into pathogen diversity, transmission dynamics, antimicrobial resistance, and outbreak surveillance. For instance, in July 2023, according to UNAIDS, the Switzerland-based UN program dedicated to addressing the global HIV/AIDS epidemic, the number of people with HIV currently exceeded 39 million globally, up 3.17% from 37.7 million in 2020. Moreover, in 2022, there were almost 1.3 million new cases of HIV infection recorded. Furthermore, in March 2023, according to the Centers for Disease Control and Prevention, a US-based government agency, tuberculosis (TB) cases in the US increased by 5.9% from 7,874 cases in 2021 to 8,331 cases in 2022. Therefore, the surge in the prevalence of infectious diseases is driving growth in the metagenomic sequencing market.
Market Trends –
Major companies operating in the metagenomic sequencing market are focusing on innovating sequencing services, to improve sequencing accuracy, throughput, and cost-effectiveness. Sequencing services refer to cutting-edge genomic technologies that enable the sequencing of longer DNA fragments, providing a more comprehensive view of genetic structures compared to traditional short-read methods. For instance, in April 2024, Clinical Microbiomics A/S, a Denmark-based biotechnology company, launched advanced long-read sequencing services, including 16S, ITS, 18S rRNA, custom gene sequencing, and comprehensive genomics and metagenomics, which provide unparalleled resolution and quality in microbial analysis, enabling detailed insights into microbial communities and facilitating the creation of high-quality metagenome-assembled genomes.
The metagenomic sequencing market covered in this report is segmented –
1) By Product And Service: Reagents And Consumables, Instruments, Sequencing Services, Analysis And Data Interpretation Solutions
2) By Technology: 16S Rrna Sequencing, Shotgun Metagenomic Sequencing, Whole-Genome Sequencing And De Novo Assembly, Metatranscriptomics
3) By Application: Clinical Diagnostic, Environmental Remediation, Gut Microbe Characterization, Drug Discovery, Biofuel, Agriculture, Other Applications
Get an inside scoop of the metagenomic sequencing market, Request now for Sample Report @
https://www.thebusinessresearchcompany.com/sample.aspx?id=16117&type=smp
Regional Insights –
North America was the largest region in the metagenomic sequencing market in 2023. Asia-Pacific is expected to be the fastest growing region in the market. The regions covered in the metagenomic sequencing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Key Companies –
Major companies operating in the metagenomic sequencing market are F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Merck Co. & KGaA, Eurofins Scientific SE, PerkinElmer Inc., Illumina Inc., Bio-Rad Laboratories Inc., QIAGEN N.V., Beijing Genomics Institute Group, Azenta Inc., Promega Corporation, Novogene Co. Ltd., Oxford Nanopore Technologies plc, Zymo Research Corporation, Metagenomi Inc., Psamogen Inc., IntegraGen SA, Karius Inc., DNAStar Inc., Macrogen Inc., Takara Bio Inc., Arc Bio LLC, Microsynth AG, Computomics GmbH, COSMOSID Inc., Phase Genomics Inc., Era7 Bioinformatics GmbH
Table of Contents
1. Executive Summary
2. Metagenomic Sequencing Market Characteristics
3. Metagenomic Sequencing Market Trends And Strategies
4. Metagenomic Sequencing Market – Macro Economic Scenario
5. Global Metagenomic Sequencing Market Size and Growth
………….
32. Global Metagenomic Sequencing Market Competitive Benchmarking
33. Global Metagenomic Sequencing Market Competitive Dashboard
34. Key Mergers And Acquisitions In The Metagenomic Sequencing Market
35. Metagenomic Sequencing Market Future Outlook and Potential Analysis
36. Appendix
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: [email protected]
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
